HBI 2024 Logo

Wednesday June 12, 2024

Sector in focus: Diagnostic imaging


This sector has seen a huge M&A boom as investors continue to consolidate particularly in Western Europe. Governments are also pumping money into the sector to increase access to diagnosis and bring down waiting times. Groups are adopting new models to integrate more services and offerings for the patient. The impact of digital transformation and AI is advanced in the sector particularly for efficiency and productivity. This session shares examples through case studies of how this innovation is driving quality and access and changing the business model and what this means for providers and investors

Speakers include:

Dr Arjun Kalyanpur, CEO, Teleradiology Solutions
Zisis Sotiriou, Group Chief Operating Office, evidia
Antoine Jomier, CEO & Founder, Incepto Medical
Moderated by Chris O’Donnell, Head of Content, HBI

 

Speakers


Dr Arjun Kalyanpur
Dr Arjun KalyanpurCEO / FounderTeleradiology Solutions
Zisis Sotiriou
Zisis SotiriouGroup COOEvidia
Antoine Jomier
Antoine JomierCEO & Co FounderIncepto Medical
Chris O'Donnell
Chris O'DonnellHead of ContentHBI

Explore more sessions

View the agenda and see how this event will accelerate your business goals.

Explore similar sessions

2:00 pmSector Analysis

Laboratory diagnostics – Growth beyond consolidation

With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively?...

Joe Stringer
Joe StringerExecutive ChairmanAutomata
Jean-François Pomerol
Jean-François PomerolChief Executive Officer & Co-FounderTribun Health
Jérôme Thill
Jérôme ThillPartnerHorasis Partners
Dr Stephan Rau
Dr Stephan RauPartnerMcDermott Will & Emery
Read more

Laboratory diagnostics – Growth beyond consolidation


With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively? Is there a threat from blood testing start-ups that are like Theranos, but work? This session features three laboratory diagnostic CEOs who share their approaches to growth.

Speakers include:

Joe Stringer, Executive Chairman, Automata

Case Study: The future of automation in labs, Automata, and The Royal Marsden
With the demand for genomic testing on the back of screening programs exploding, how are lab groups managing to keep up? Lab automation group, Automata has enabled providers such as a The Royal Marsden NHS Trust to increase genomic test throughput by 3 to 5x whilst simultaneously halving the space required. In this case study Joe explains how this was possible, the future of innovation in laboratories, the impact on the scientific workforce and productivity, and why logistics is now the only significant barrier to scaling innovation.

Jean-Francois Pomerol, CEO & Co-Founder, Tribun Health
Jérôme Thill, Partner, Horasis
Moderated by Dr Stephan Rau, Partner, McDermott, Will & Emery

 

Speakers


Joe Stringer
Joe StringerExecutive ChairmanAutomata
Jean-François Pomerol
Jean-François PomerolChief Executive Officer & Co-FounderTribun Health
Jérôme Thill
Jérôme ThillPartnerHorasis Partners
Dr Stephan Rau
Dr Stephan RauPartnerMcDermott Will & Emery
5:00 pmSector Analysis

From reactive to proactive: How data and prevention are re-shaping healthcare business models

The global push for a preventative versus reactive approach to healthcare combined with digital technology is altering the business model for all healthcare providers. Each has the opportunity to leverage...

Rick VanNess
Rick VanNessLaboratory Data ExpertAlbuquerque NM
Nelli Såger
Nelli SågerDevelopment DirectorMehiläinen
Prof Dr med Christian Schmidt
Prof Dr med Christian SchmidtCEOLifeLink Medical
Dr Matthew Prime
Dr Matthew PrimeHead of Healthcare Expertise & Evidence Generation Roche Information Solutions
Read more

From reactive to proactive: How data and prevention are re-shaping healthcare business models


The global push for a preventative versus reactive approach to healthcare combined with digital technology is altering the business model for all healthcare providers. Each has the opportunity to leverage their data to open up new revenue streams, cut costs and build better relationships with payors and directly with patients. For years lab service and hospital groups have sat on huge data repositories of valuable data but lacked the business models needed to turn this into something that could drive topline growth, until now. This session explores three business models that generate value from screening and routine testing and explores exactly how technology is enabling these models to be both scalable and sustainable.

Rick VanNess, Laboratory Data Expert, Albuquerque, NM
Nelli Såger, Development Director, Mehiläinen
Prof Dr med Christian Schmidt, CEO, LifeLink Medical
Moderated by Dr Matthew Prime, Global Medical Director, Roche Diagnostic Information Solutions

Speakers


Rick VanNess
Rick VanNessLaboratory Data ExpertAlbuquerque NM
Nelli Såger
Nelli SågerDevelopment DirectorMehiläinen
Prof Dr med Christian Schmidt
Prof Dr med Christian SchmidtCEOLifeLink Medical
Dr Matthew Prime
Dr Matthew PrimeHead of Healthcare Expertise & Evidence Generation Roche Information Solutions